VanEck Biotech ETF (BBH)
VanEck Biotech ETF operates in the Asset Management industry of the Financial Services sector, headquartered in New York, NY, US. The stock last traded at $245.36, up 0.65% on the session, giving a market capitalisation of $472.4M. Its beta of 0.56 implies it has historically moved less than the broad market.
The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.
VanEck Biotech ETF is most often compared with the following Financial Services names: